MedScout, a revenue acceleration platform revolutionizing commercial operations for medtech and life sciences companies, recently announced its $15M Series A funding round. MedScout led the charge during this round while Exbo Group provided support with scenario planning and forecasting through the financial model, as well as by aiding in the diligence process. 

The round was led by Fulcrum Equity Partners. Stage 2 and LiveOak Ventures, existing investors, also provided key support.

Skylar Talley, Co-Founder and CEO of Medscout, said, "After three and a half years partnering with hundreds of medtech companies, we’re thrilled to have reached this milestone. From day one, our vision has been clear: to develop a platform indispensable to every medical device rep in the field. With this new capital, we can now turn that vision into a reality."